Cargando…
In vivo therapeutic evaluation of polymeric nanomedicines: effect of different targeting peptides on therapeutic efficacy against breast cancer
Targeted nanomedicines offer many advantages over macromolecular therapeutics that rely only on passive accumulation within the tumour environment. The aim of this work was to investigate the in vivo anticancer efficiency of polymeric nanomedicines that were conjugated with peptide aptamers that sho...
Autores principales: | Zhao, Yongmei, Fletcher, Nicholas L., Liu, Tianqing, Gemmell, Anna C., Houston, Zachary H., Blakey, Idriss, Thurecht, Kristofer J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170333/ https://www.ncbi.nlm.nih.gov/pubmed/30324082 http://dx.doi.org/10.7150/ntno.27142 |
Ejemplares similares
-
Investigation of a Dual siRNA/Chemotherapy Delivery
System for Breast Cancer Therapy
por: Zhao, Yongmei, et al.
Publicado: (2022) -
Confinement of Therapeutic Enzymes in Selectively
Permeable Polymer Vesicles by Polymerization-Induced Self-Assembly
(PISA) Reduces Antibody Binding and Proteolytic Susceptibility
por: Blackman, Lewis D., et al.
Publicado: (2018) -
RAFT Polymer–Antibody
Conjugation: Squaramide
Ester Chemistry Leads to Conjugates with a Therapeutic Anti-EGFR Antibody
with Full Retention of Activity and Increased Tumor Uptake In Vivo
por: Ardana, Aditya, et al.
Publicado: (2023) -
Therapeutic efficacy of nanomedicines for prostate cancer: An update
por: Lakshmanan, Vinoth-Kumar
Publicado: (2016) -
Understanding the Uptake of Nanomedicines at Different
Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision
Bispecific Antibodies
por: Houston, Zachary H., et al.
Publicado: (2020)